Nektar Therapeutics (NKTR) Inventory (2010 - 2024)

Nektar Therapeutics' Inventory history runs 15 years deep, the most recent figure standing at $14.5 million for Q2 2024.

• On a quarterly basis, Inventory fell 30.08% year-over-year to $14.5 million in Q2 2024; TTM through Jun 2024 was $14.5 million, a 30.08% decrease from a year earlier, with the FY2023 full-year figure at $16.1 million, down 16.15% from the prior year.
• Inventory retreated to $14.5 million in Q2 2024 per NKTR's latest filing, from $16.2 million in the prior quarter.
• Across five years, Inventory topped out at $20.7 million in Q2 2023 and bottomed at $12.6 million in Q2 2020.
• The 5-year median for Inventory is $15.6 million (2021), against an average of $16.2 million.
• Across the five-year window, Inventory surged 31.58% in 2023 and slumped 30.08% in 2024, its largest moves.
• Year by year, Inventory stood at $15.3 million in 2020, then increased by 3.33% to $15.8 million in 2021, then advanced by 21.52% to $19.2 million in 2022, then slipped by 16.15% to $16.1 million in 2023, then fell by 10.16% to $14.5 million in 2024.
• Per Business Quant, the three latest NKTR Inventory figures stand at $14.5 million (Q2 2024), $16.2 million (Q1 2024), and $16.1 million (Q4 2023).